Search

everythinglearnresearchcommunity

for

Search:↓

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Exosome-based therapies show promise for treating alopecia areata but need more research.

The AI tool helped primary care doctors and nurse practitioners diagnose skin conditions more accurately.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Five FDA-approved drugs may help block COVID-19 virus entry.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Hair loss in men treated best with early medication or transplant, new treatments researched.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Hair testing is a reliable method for detecting workplace drug use when done with proper sample preparation and confirmation.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.